The Weekly Litigation News Digest is now live. Subscribe now

Integrin Alpha(V)Beta(6) For Diagnosis/Prognosis Of Colorectal Carcinoma - EP2979096

The patent EP2979096 was granted to Universitt Zrich on May 10, 2017. The application was originally filed on Mar 27, 2014 under application number EP14712691A. The patent is currently recorded with a legal status of "Revoked".

EP2979096

UNIVERSITT ZRICH
Application Number
EP14712691A
Filing Date
Mar 27, 2014
Status
Revoked
Jan 4, 2019
Publication Date
May 10, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK PATENTFeb 12, 2018-ADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP1754714
DESCRIPTIONUS7150871
INTERNATIONAL-SEARCH-REPORTEP0628820
OPPOSITIONUS2012309018
OPPOSITIONUS8398975
OPPOSITIONWO2008112004
OPPOSITIONWO2010065968

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents